The future of 3D culture systems in cancer research looks promising. Advances in microfluidics and organoids are likely to further enhance the capabilities of these systems. Microfluidic devices can simulate the dynamic environment of blood flow and nutrient exchange, while organoids can replicate the architecture and function of entire organs.
